Nine Malaysian hospitals to work with WHO for drug trials on COVID-19

By Akshay Kedari  Date: 2020-04-06

Nine Malaysian hospitals to work with WHO for drug trials on COVID-19

With the growing COVID-19 crisis, various initiatives are being taken worldwide where numerous organizations of various scale and are contributing as much as they can towards the efforts. The WHO, the biggest global authority responsible for international public health, is planning a solidarity trial to test various drugs that could help fight the coronavirus.

In a recent press release, the WHO, in collaboration with the Health Ministry of Malaysia, announced that the country has been selected to be a participant in the “Solidarity Trial”. Nine hospitals across Malaysia have been selected and would very soon initiate drug testing for coronavirus.   

Health Director-General, Datuk Dr. Noor Hisham Abdullah stated that the Health Ministry has expedited the process to conduct drug testing for the treatment of coronavirus patients. The trials would be conducted under the safety standards that are set by the National Pharmaceutical Regulatory Agency.

Dr. Noor further added that the participation of Malaysia in this global trial might help discover life-saving medicines to combat COVID-19 by evaluating their effectiveness and safety. Clinical Research Malaysia and Institute for Clinical Research of the Health Ministry of Malaysia would also help with the implementation of drug trials across the nation.

Queen Elizabeth Hospital, Sarawak General Hospital, Tengku Ampuan Afzan Hospital, Melaka Hospital, Kuala Lumpur Hospital, Sungai Buloh Hospital, Penang Hospital, Sultanah Bahiyah Hospital, and Tuanku Fauziah Hospital are the nine hospitals that have been selected from Malaysia to conduct trails of several drugs.       

Dr. Chow Ting Soo will lead the research and drug trials in Malaysia, and would also have access to a team of 16 Infectious Disease pharmacists and physicians working in their respective hospitals. Dr. Soo is an Infectious Disease Consultant in Penang Hospital.

The drug trials would primarily test the effectiveness of four different treatment protocols utilizing various combinations of five drugs which include Hydroxychloroquine, Chloroquine, Interferon beta, Lopinavir/Ritonavir, and Remdesivir.

Source credit: https://www.thestar.com.my/news/nation/2020/04/06/covid-19-nine-m039sian-hospitals-to-start-who-global-drug-trial

About Author

Akshay Kedari     aeresearch.net

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Klevu launches Discovery Suite to boost online retail conversion rates

Klevu launches Discovery Suite to boost online retail conversion rates

By Akshay Kedari

Klevu Oy, a leading provider of AI-based search technologies for online retailers, has reportedly launched a comprehensive solution called Discovery Suite that can allow brands to capture shoppers’ intent in order to improve their conversion ra...

SK Group acquires 16.3% stake in VinCommerce for USD 410 million

SK Group acquires 16.3% stake in VinCommerce for USD 410 million

By Akshay Kedari

SK Group of South Korea has purchased 16.3% of Vincommerce, Vietnams leading retail business operator, for USD 410 million in a bid to broaden its presence in the Southeast Asian region’s customer retailer sector. Sources close to the matter s...

Snapchat exploring options to bypass Apple’s upcoming privacy policies

Snapchat exploring options to bypass Apple’s upcoming privacy policies

By Akshay Kedari

Reportedly, American camera and social media company Snap Inc. is exploring different methods to circumvent Apple’s upcoming privacy regulations which will prohibit apps from collecting iPhone user information. Apple’s highly controversi...

SK Innovation might pull its battery business from the United States

SK Innovation might pull its battery business from the United States

By Akshay Kedari

SK Innovation Co., a South Korea-based petrochemical, energy, and e-mobility battery manufacturer, has recently announced its plans of withdrawing its battery operations from America if U.S. President Joe Biden fails to overrule a trade panel decisio...

Jeep planning to establish EV charging networks near off-road routes

Jeep planning to establish EV charging networks near off-road routes

By Akshay Kedari

Jeep, the American multinational automobile manufacturer, is reportedly planning to develop EV charging networks near or at off-road routes across several locations in the U.S, in a bid to look beyond conventional roads and to offer consistent chargi...